Researchers at Columbia University also analyzed the anti prostate cancer effects of another natural compound, modified citrus pectin (MCP), in prostate cells lines from humans and mice. The results show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent prostate cancer cells. Dr. Jun Yan, lead author, explains, "Our findings clearly demonstrate that MCP possesses anti-prostate cancer properties in both androgen-dependent (hormonal sensitive) and androgen-independent (hormonal resistant) prostate cancer cells. These results strongly suggest that MCP can be a promising chemopreventive and therapeutic agent against this malignancy."

Even further anti-cancer results were found with another important new study, conducted by researchers at the Cancer Research Laboratory at the Methodist Research Institute, IN, and Indiana University Cancer Center. They analyzed the synergistic effects of MCP and Dr. Eliaz's multinutrient prostate support formula, with extremely positive results. The findings suggest that the combination of the two markedly further enhanced inhibition of invasive behavior of prostate cancer cells. Dr. Eliaz states "This research indeed demonstrates the strong synergistic effect of a multifaceted approach to prostate cancer treatment."

Based on the principals of integrative medicine, Dr. Isaac Eliaz recommends a multi-dimensional treatment plan to fight and prevent prostate cancer from all angles. He states, "The integrative and synergistic effects shown here present a unique approach to cancer treatment because they draw from multiple medical systems, and strategically combine ancient wisdom, modern science, and extensive clinical experience."

Research published in: Integrative Cancer Therapies

SOURCE Better Health Publishing